Immunoprecise Antibodies Stock Price on June 2, 2021
IPA Stock | USD 1.11 0.39 0.00% |
If you're considering investing in Immunoprecise Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immunoprecise Antibodies stands at 1.52, as last reported on the 28th of March, with the highest price reaching 1.64 and the lowest price hitting 1.50 during the day. We consider Immunoprecise Antibodies extremely dangerous. Immunoprecise Antibodies holds Efficiency (Sharpe) Ratio of 0.001, which attests that the entity had a 0.001% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Immunoprecise Antibodies, which you can use to evaluate the volatility of the firm. Please check out Immunoprecise Antibodies' Risk Adjusted Performance of 0.0097, downside deviation of 5.02, and Market Risk Adjusted Performance of 0.0087 to validate if the risk estimate we provide is consistent with the expected return of 0.0067%.
Immunoprecise Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Immunoprecise |
Sharpe Ratio = 0.001
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | IPA |
Estimated Market Risk
6.47 actual daily | 57 57% of assets are less volatile |
Expected Return
0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immunoprecise Antibodies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunoprecise Antibodies by adding Immunoprecise Antibodies to a well-diversified portfolio.
Immunoprecise Antibodies Valuation on June 2, 2021
It is possible to determine the worth of Immunoprecise Antibodies on a given historical date. On June 2, 2021 Immunoprecise was worth 3.77 at the beginning of the trading date compared to the closed value of 3.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunoprecise Antibodies stock. Still, in general, we apply an absolute valuation method to find Immunoprecise Antibodies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunoprecise Antibodies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunoprecise Antibodies' related companies.
Open | High | Low | Close | Volume | |
03/15/2022 | 3.77 | 4.00 | 3.73 | 3.95 | 108,364 |
3.95 | 4.22 | 3.79 | 3.91 | 67,287 |
Backtest Immunoprecise Antibodies | | | Immunoprecise Antibodies History | | | Immunoprecise Antibodies Valuation | Next |
Immunoprecise Antibodies Trading Date Momentum on June 2, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Immunoprecise Antibodies Fundamentals Correlations and Trends
By evaluating Immunoprecise Antibodies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunoprecise Antibodies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunoprecise financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immunoprecise Antibodies Stock history
Immunoprecise Antibodies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunoprecise is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunoprecise Antibodies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunoprecise Antibodies stock prices may prove useful in developing a viable investing in Immunoprecise Antibodies
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada. Immunoprecise Antibodies is traded on NASDAQ Exchange in the United States.
Immunoprecise Antibodies Stock Technical Analysis
Immunoprecise Antibodies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immunoprecise Antibodies Period Price Range
Low | March 15, 2022
| High |
3.77 | 3.95 |
Immunoprecise Antibodies March 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Immunoprecise Antibodies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunoprecise Antibodies shares will generate the highest return on investment. By undertsting and applying Immunoprecise Antibodies stock market strength indicators, traders can identify Immunoprecise Antibodies entry and exit signals to maximize returns
Immunoprecise Antibodies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunoprecise Antibodies' price direction in advance. Along with the technical and fundamental analysis of Immunoprecise Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunoprecise to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0097 | |||
Jensen Alpha | (0.32) | |||
Total Risk Alpha | (1.46) | |||
Sortino Ratio | (0.03) | |||
Treynor Ratio | (0) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunoprecise Antibodies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as various price indices. For information on how to trade Immunoprecise Stock refer to our How to Trade Immunoprecise Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Immunoprecise Stock analysis
When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunoprecise Antibodies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.